University of Nottingham: New partnership will help tackle chronic pain
Members of the public are invited learn how this important area of research will be addressed and to officially see the launch of the Advance Pain Discover Platform (APDP), at a webinar on the 9 May from 10am – 12midday.
The problem of pain still blights the lives of far too many people. Around a third of the population in Britain have chronic pain. This long-lasting pain affects so many aspects of people’s lives, their ability to work and personal relationships.
The UK has been the cornerstone of pain research. The APDP is a new, unique partnership that has developed from a shared vision, funded by government, charities and the private sector. It is a multi-million pound, long-term initiative that will generate research science to break through the complexity of pain.
The APDP brings people with lived experience of pain together with UK excellence in chronic pain research across diagnoses, disciplines, academic, clinical and commercial communities.
Together, through the APDP, we will transform people’s understanding of pain. We will uncover shared mechanisms and break down inconsistencies in diagnosis and treatment. “We will uncover genes and molecules, brain structure and function, psychological and social mechanisms, drug and non-drug treatments. Those who are forced to live with intolerable pain are being noticed. Our multidisciplinary approach will ultimately improve the lives of people living with pain conditions and their families.” “We will uncover genes and molecules, brain structure and function, psychological and social mechanisms, drug and non-drug treatments. Those who are forced to live with intolerable pain are being noticed. Our multidisciplinary approach will ultimately improve the lives of people living with pain conditions and their families.”
Professor David Walsh, co-Director of Pain Centre Versus Arthritis, in the School of Medicine at the University of Nottingham is the academic Director leading the partnership.
The webinar will convey for a public audience the specific and shared ambitions of each of the 18 current APDP components. Attendees will see the depth and breadth of UK capability in pain research, and have an opportunity to initiate new links with our experts.